{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:31:34Z","timestamp":1763533894735},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT), Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior, Portugal"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.exppara.2013.05.015","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T09:05:34Z","timestamp":1370509534000},"page":"36-41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs"],"prefix":"10.1016","volume":"135","author":[{"given":"Carla","family":"Maia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Rol\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenea","family":"Campino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2013.05.015_b0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2013.05.015_b0010","first-page":"859","article-title":"Epidemiology of leishmaniases in Portugal","volume":"23","author":"Campino","year":"2010","journal-title":"Acta M\u00e9d. Port."},{"key":"10.1016\/j.exppara.2013.05.015_b0015","series-title":"Drug Resistance in Leishmania Parasites \u2013 Consequences, Molecular Mechanism and Possible Treatments","first-page":"45","article-title":"The role of reservoirs: canine leishmaniasis","author":"Campino","year":"2012"},{"key":"10.1016\/j.exppara.2013.05.015_b0020","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1365-3156.2006.01728.x","article-title":"Leishmaniasis in Portugal: enzyme polymorphism of Leishmania infantum based on the identification of 213 strains","volume":"11","author":"Campino","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2013.05.015_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/expr.2000.4537","article-title":"Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions","volume":"95","author":"Carri\u00f3","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2210-2-11","article-title":"In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate","volume":"2","author":"Carri\u00f3","year":"2002","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.exppara.2013.05.015_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jac\/47.1.120","article-title":"In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients","volume":"47","author":"Carri\u00f3","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2013.05.015_b0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0001-706X(01)00125-5","article-title":"In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain","volume":"79","author":"Carri\u00f3","year":"2001","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2013.05.015_b0045","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijpara.2008.03.005","article-title":"Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII","volume":"38","author":"Choudhury","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0050","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"Cojean","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.05.015_b0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vetpar.2012.04.028","article-title":"Risk factors for canine leishmaniasis \u2013 a Portuguese national survey","volume":"189","author":"Cortes","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy \u2013 challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.exppara.2013.05.015_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2013.05.015_b0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1550-7408.2002.tb00369.x","article-title":"Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasite","volume":"49","author":"Dey","year":"2002","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.exppara.2013.05.015_b0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3201\/eid1203.050811","article-title":"Canine visceral leishmaniasis, United States and Canada, 2000\u20132003","volume":"12","author":"Duprey","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.05.015_b0075","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/AAC.42.8.2141","article-title":"Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis","volume":"42","author":"Durand","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.05.015_b0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2013.05.015_b0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis","volume":"41","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.05.015_b0090","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00436-011-2792-7","article-title":"Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum","volume":"110","author":"Farca","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.05.015_b0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.resmic.2004.01.001","article-title":"In vitro assays for evaluation of drug activity against Leishmania spp","volume":"155","author":"Fumarola","year":"2004","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.exppara.2013.05.015_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2008.02144.x","article-title":"Drug regimens for visceral leishmaniasis in Mediterranean countries","volume":"13","author":"Gradoni","year":"2008","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2013.05.015_b0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0195","series-title":"Fourth World Congress on Leishmaniasis","first-page":"273","article-title":"Post-treatment Sb-susceptibility of Leishmania infantum clinical isolates of dogs","author":"Luz","year":"2009"},{"key":"10.1016\/j.exppara.2013.05.015_b0115","first-page":"105","article-title":"Infectivity of Leishmania infantum treated with amphotericin B plus Phlebotomus salivary gland in BALB\/c mice","volume":"6","author":"Maia","year":"2009","journal-title":"Int. J. Integr. Biol."},{"key":"10.1016\/j.exppara.2013.05.015_b0120","first-page":"123","article-title":"Infectivity of five different types of macrophages by Leishmania infantum","volume":"90","author":"Maia","year":"2007","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2013.05.015_b0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762011000400015","article-title":"The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil","volume":"106","author":"Morais-Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2013.05.015_b0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","article-title":"Leishmania spp.: proficiency of drug-resistant parasites","volume":"29","author":"Natera","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2013.05.015_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.exppara.2013.05.015_b0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jac\/dkf113","article-title":"In vitro susceptibility of Leishmania infantum strains isolated from Spanish HIV-positive patients to Abelcet and Fungizone","volume":"50","author":"Pi\u00f1ero","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2013.05.015_b0145","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijpara.2006.06.019","article-title":"First report of genetic hybrids between two very divergent Leishmania species: Leishmania infantum and Leishmania major","volume":"36","author":"Ravel","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vetpar.2005.04.013","article-title":"Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas","volume":"130","author":"Saridomichelakis","year":"2005","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in Leishmania cell based drug-screening procedures","volume":"56","author":"Sereno","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2013.05.015_b0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpddr.2012.07.003","article-title":"Antimony resistance and environment: elusive links to explore during Leishmania life cycle","volume":"2","author":"Sereno","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2013.05.015_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0170","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.05.015_b0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijpara.2007.02.002","article-title":"Increased transmission potential of Leishmania major\/Leishmania infantum hybrids","volume":"37","author":"Volf","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.05.015_b0180","unstructured":"WHO, 2010. Working to overcome the global impact of neglected tropical diseases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases No. 949, Geneva, Switzerland."},{"key":"10.1016\/j.exppara.2013.05.015_b0185","unstructured":"WHO, 2005. Report of a WHO informal consultation on liposomal amphotericin B in the treatment of visceral leishmaniasis. WHO\/CDS\/NTD\/IDM\/2007.4: Rome, Italy."},{"key":"10.1016\/j.exppara.2013.05.015_b0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mimet.2003.08.013","article-title":"Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania","volume":"55","author":"Williams","year":"2003","journal-title":"J. Microbiol. Methods"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T20:15:46Z","timestamp":1563135346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489413001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0014489413001550"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2013.05.015","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2013.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}